ZYME Q3 2022 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-40.1% YoY

Gross Profit

-$34M-1310.0% margin

Operating Income

-$50M-1914.0% margin

Net Income

-$48M-1818.5% margin

EPS (Diluted)

$-0.72

QoQ Revenue Growth

-51.7%

Cash Flow

Operating Cash Flow

-$73M

Free Cash Flow

-$77M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$300M

Total Liabilities

$121M

Stockholders' Equity

$180M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-40.1%
Gross Profit	-$34M	-$45M	+24.2%
Operating Income	-$50M	-$61M	+17.4%
Net Income	-$48M	-$61M	+21.0%

Revenue Segments

Other Product

$3M100%